Stocks › AMED

AMED

AMED·USD
—
No end-of-day price on record
AMED
AMED
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AMEDS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of AMED by members of U.S. Congress · 6 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Lisa C. McClainLisa C. McClainHouse · R · MI AMEDAMED · Stock Sale
$1,001 - $15,000
Sep 12, 2025 Aug 18, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI AMEDAMED · Stock Purchase
$1,001 - $15,000
Aug 13, 2025 Jun 9, 2025 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT AMEDAMED · Stock Sale
$1,001 - $15,000
Nov 9, 2020 Oct 13, 2020 Filing ↗
Donna ShalalaDonna ShalalaHouse · D · FL AMEDAMED · Stock Sale
$1,001 - $15,000
Apr 27, 2020 Jun 24, 2019 Filing ↗
Donna ShalalaDonna ShalalaHouse · D · FL AMEDAMED · Stock Sale
$1,001 - $15,000
Apr 27, 2020 Apr 16, 2019 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT AMEDAMED · Stock Purchase
$100,001 - $250,000
Jul 1, 2019 May 30, 2019 Filing ↗

Whale Activity

Position changes in AMED reported for 2025-06-30 by 5 tracked institutional filers
Increased: 2Decreased: 3
  • Increased2
  • New0
  • Held0
  • Decreased3
  • Closed0
  • No prior filing0
FilerSharesValueChange
BlackRock, Inc.3.3M$329.2Mincreased
Vanguard Group3.0M$299.2Mdecreased
Millennium Management LLC441.7K$43.5Mdecreased
Renaissance Technologies364.1K$35.8Mincreased
Citadel Advisors LLC128.9K$12.7Mdecreased

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by AMED insiders, by quarter · Form 4
-2,500-1,25001,2502,5002025 Q1: -2,0412025 Q12025 Q2: -3742025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

1,355 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Coye Molly JoelDirector Disposition to issuer −8,818 — — Aug 14, 2025 Form 4 ↗
Klapstein Julie DDirector Disposition to issuer −16.0K — — Aug 14, 2025 Form 4 ↗
Kusserow Paul B. K.Director Disposition to issuer −621 — — Aug 14, 2025 Form 4 ↗
Kusserow Paul B. K.Director Disposition to issuer −439.1K — — Aug 14, 2025 Form 4 ↗
Rideout Jeffrey ADirector Disposition to issuer −9,335 — — Aug 14, 2025 Form 4 ↗
Muscato NickChief Strategy Officer Disposition to issuer −212 — — Aug 14, 2025 Form 4 ↗
Muscato NickChief Strategy Officer Disposition to issuer −3,468 — — Aug 14, 2025 Form 4 ↗
Muscato NickChief Strategy Officer Option exercise +3,468 $0.00 $0 Aug 14, 2025 Form 4 ↗
Muscato NickChief Strategy Officer Disposition to issuer −32.6K — — Aug 14, 2025 Form 4 ↗
Muscato NickChief Strategy Officer Disposition to issuer −3,067 — — Aug 14, 2025 Form 4 ↗
Kline Teresa L.Director Disposition to issuer −9,818 — — Aug 14, 2025 Form 4 ↗
CAPPS VICKIE LDirector Disposition to issuer −9,818 — — Aug 14, 2025 Form 4 ↗
Griffin Jennifer GChief Legal Officer Disposition to issuer −341 — — Aug 14, 2025 Form 4 ↗
Griffin Jennifer GChief Legal Officer Disposition to issuer −9,132 — — Aug 14, 2025 Form 4 ↗
Griffin Jennifer GChief Legal Officer Disposition to issuer −10.7K — — Aug 14, 2025 Form 4 ↗
Ginn Scott GEVP, CFO & COO Disposition to issuer −2,714 — — Aug 14, 2025 Form 4 ↗
Ginn Scott GEVP, CFO & COO Disposition to issuer −10.4K — — Aug 14, 2025 Form 4 ↗
Ginn Scott GEVP, CFO & COO Option exercise +10.4K $0.00 $0 Aug 14, 2025 Form 4 ↗
Ginn Scott GEVP, CFO & COO Disposition to issuer −60.5K — — Aug 14, 2025 Form 4 ↗
Ginn Scott GEVP, CFO & COO Disposition to issuer −31.2K — — Aug 14, 2025 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding AMED · SEC Form N-PORT

Funds report their holdings by CUSIP, and AMED could not be matched to one, so no fund holdings are shown.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • GOLDMAN SACHS & CO. LLCSCHEDULE 13G/A · passive (13G) · 190 shares0.0%
    Nov 14, 2025 · ↗
  • THE GOLDMAN SACHS GROUP, INC.SCHEDULE 13G/A · passive (13G) · 190 shares0.0%
    Nov 14, 2025 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming AMED as client

No lobbying filings found naming AMED as the client.

Government Contracts

Federal awards to AMED · USAspending

No federal contract awards found for AMED.

U.S. Patents

Recent USPTO applications naming AMED

No USPTO patent applications found for AMED.

Annual Financials

From AMED's 10-K filings · XBRL

No annual XBRL figures on record for AMED. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history
  • 4-for-3Stock splitDec 5, 2006

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About AMED

From SEC EDGAR company records

No company profile on record.